Fetal adverse drug reactions with biologic Disease Modifying Anti-Rheumatic Drugs used during pregnancy: Insights from a World Health Organization pharmacovigilance database study (VigiBase (R)) - Université de Picardie Jules Verne Accéder directement au contenu
Article Dans Une Revue Fundamental & Clinical Pharmacology Année : 2022

Fetal adverse drug reactions with biologic Disease Modifying Anti-Rheumatic Drugs used during pregnancy: Insights from a World Health Organization pharmacovigilance database study (VigiBase (R))

Fichier non déposé

Dates et versions

hal-03712137 , version 1 (02-07-2022)

Identifiants

  • HAL Id : hal-03712137 , version 1

Citer

A. Dernoncourt, S. Liabeuf, Youcef Bennis, K. Masmoudi, V. Gras-Champel, et al.. Fetal adverse drug reactions with biologic Disease Modifying Anti-Rheumatic Drugs used during pregnancy: Insights from a World Health Organization pharmacovigilance database study (VigiBase (R)). Fundamental & Clinical Pharmacology, 2022, 36 (1, SI), pp.32. ⟨hal-03712137⟩
25 Consultations
0 Téléchargements

Partager

Gmail Facebook Twitter LinkedIn More